1. Search Result

Search Result

Results for "1257628-64-0" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-101489
    GZD856

    PDGFR Bcr-Abl Cancer
    GZD856 is a novel and orally bioavailable PDGFRα/β inhibitor with IC50s of 68.6 and 136.6 nM, respectively. Anti-lung cancer activities. Also a Bcr-Abl T315I inhibitor with IC50s of 19.9 and 15.4 nM for Bcr-Abl and T315I mutant.